Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

X-Linked Retinitis Pigmentosa (XLRP) Clinical Trials

3 recruiting trials for X-Linked Retinitis Pigmentosa (XLRP). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors

Recruiting Trials

RECRUITINGPhase 2NCT07174726

A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male...

The purpose of this Phase 2 Study is to see if the investigational study drug, laruparetigene zovaparvovec, also known as AGTC-501, given in both eyes, is safe and works to...

Sponsor: Beacon TherapeuticsEnrolling: 106 locations
RECRUITINGNCT06982417

InsightRP2 Registry

InsightRP2 is a secure online patient registry specific to RP2-associated retinitis pigmentosa (RP). It is our goal to further the scientific understanding of this rare disease...

Sponsor: University of GöttingenEnrolling: 2001 location
RECRUITINGPhase 1 / Phase 2NCT06492850

Gene Therapy for RPGR Gene Mutation-associated X-linked Retinitis Pigmentosa

The aim of this study was to evaluate the safety, tolerability, and efficacy of one-time subretinal injection of FT-002 in male subjects (8-45 years of age) with RPGR (Retinitis...

Sponsor: Frontera TherapeuticsEnrolling: 321 location